möglich sobald bei der ZB eingereicht worden ist.
At the right time: Moving precision therapy to newly diagnosed cancer.
Med. 5, 1463-1465 (2024)
Precision oncology aims to match the right drug(s) to the right patient. Equally important is ensuring that precision therapies are offered at the right time. Transformative, rather than incremental, outcome improvement may require treatment at diagnosis rather than in the advanced/metastatic setting after genomic evolution.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Letter to the Editor
ISSN (print) / ISBN
2666-6359
e-ISSN
2666-6340
Zeitschrift
Med (N Y)
Quellenangaben
Band: 5,
Heft: 12,
Seiten: 1463-1465
Verlag
Cell Press
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Metabolism and Cell Death (MCD)